BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20000948)

  • 1. Effect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruption.
    Yang FY; Liu SH; Ho FM; Chang CH
    J Acoust Soc Am; 2009 Dec; 126(6):3344-9. PubMed ID: 20000948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation.
    Yang FY; Lin YS; Kang KH; Chao TK
    J Control Release; 2011 Feb; 150(1):111-6. PubMed ID: 21070825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of drug delivery enhanced by acoustic pressure during blood-brain barrier disruption induced by focused ultrasound.
    Yang FY; Lee PY
    Int J Nanomedicine; 2012; 7():2573-82. PubMed ID: 22679368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption.
    Yang FY; Fu WM; Yang RS; Liou HC; Kang KH; Lin WL
    Ultrasound Med Biol; 2007 Sep; 33(9):1421-7. PubMed ID: 17561334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption.
    Yang FY; Fu WM; Chen WS; Yeh WL; Lin WL
    Ultrason Sonochem; 2008 Apr; 15(4):636-643. PubMed ID: 17910929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning.
    Yang FY; Chen CC; Kao YH; Chen CL; Ko CE; Horng SC; Chen RC
    Ultrasound Med Biol; 2013 Apr; 39(4):620-7. PubMed ID: 23384461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to diagnostic ultrasound impacts blood-brain barrier permeability in rats.
    Yang FY; Lin GL; Horng SC; Chen RC
    Ultrasound Med Biol; 2012 Jun; 38(6):1051-7. PubMed ID: 22424599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse sequence and timing of contrast-enhanced MRI for assessing blood-brain barrier disruption after transcranial focused ultrasound in the presence of hemorrhage.
    Weng JC; Wu SK; Yang FY; Lin WL; Tseng WY
    J Magn Reson Imaging; 2010 Jun; 31(6):1323-30. PubMed ID: 20512883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
    Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
    Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model.
    Yang FY; Lin GL; Horng SC; Chang TK; Wu SY; Wong TT; Wang HE
    IEEE Trans Ultrason Ferroelectr Freq Control; 2011 May; 58(5):964-70. PubMed ID: 21622052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound.
    Yang FY; Horng SC; Lin YS; Kao YH
    J Magn Reson Imaging; 2010 Sep; 32(3):593-9. PubMed ID: 20815056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
    Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
    J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acoustic cavitation-based monitoring of the reversibility and permeability of ultrasound-induced blood-brain barrier opening.
    Sun T; Samiotaki G; Wang S; Acosta C; Chen CC; Konofagou EE
    Phys Med Biol; 2015 Dec; 60(23):9079-94. PubMed ID: 26562661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption.
    McDannold N; Vykhodtseva N; Hynynen K
    Ultrasound Med Biol; 2008 Jun; 34(6):930-7. PubMed ID: 18294757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery.
    Hynynen K; McDannold N; Vykhodtseva N; Raymond S; Weissleder R; Jolesz FA; Sheikov N
    J Neurosurg; 2006 Sep; 105(3):445-54. PubMed ID: 16961141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide induced blood-brain barrier disruption in rats: duration of opening and histological sequelae.
    Spigelman MK; Zappulla RA; Strauchen JA; Feuer EJ; Johnson J; Goldsmith SJ; Malis LI; Holland JF
    Cancer Res; 1986 Mar; 46(3):1453-7. PubMed ID: 3510725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles.
    Deng J; Huang Q; Wang F; Liu Y; Wang Z; Wang Z; Zhang Q; Lei B; Cheng Y
    J Mol Neurosci; 2012 Mar; 46(3):677-87. PubMed ID: 21861133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
    Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
    J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.
    Hynynen K; McDannold N; Sheikov NA; Jolesz FA; Vykhodtseva N
    Neuroimage; 2005 Jan; 24(1):12-20. PubMed ID: 15588592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opening of the blood-brain barrier with an unfocused ultrasound device in rabbits.
    Beccaria K; Canney M; Goldwirt L; Fernandez C; Adam C; Piquet J; Autret G; Clément O; Lafon C; Chapelon JY; Carpentier A
    J Neurosurg; 2013 Oct; 119(4):887-98. PubMed ID: 23790118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.